Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Results symbols : XENE save search
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 21:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 5.3%
H: 2.6%
C: -5.75%
year update pharmaceuticals financial results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
Published: 2024-02-22 (Crawled : 21:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: -0.08%
H: 0.61%
C: 0.51%
conference year update pharmaceuticals financial results
Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical Trial of XEN1101 in Major Depressive Disorder (MDD)
Published: 2023-11-27 (Crawled : 12:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 0.1%
H: 18.14%
C: 17.66%
xen1101 pharmaceuticals topline trial results
Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-08 (Crawled : 21:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 3.95%
H: 2.47%
C: -10.23%
update pharmaceuticals financial results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-11-01 (Crawled : 20:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 1.06%
H: 4.96%
C: 4.82%
conference update pharmaceuticals financial results
Xenon Pharmaceuticals Announces Publication of Results from XEN1101 Phase 2b “X-TOLE” Clinical Trial in Peer-Reviewed Journal Article in JAMA Neurology
Published: 2023-10-09 (Crawled : 20:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 0.31%
H: 3.31%
C: 3.06%
xen1101 publication pharmaceuticals trial results
Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-09 (Crawled : 20:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 2.23%
H: 7.48%
C: 5.93%
update pharmaceuticals financial results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Second Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-08-02 (Crawled : 20:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: -0.24%
H: 1.41%
C: -0.16%
conference update pharmaceuticals financial results
Xenon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-09 (Crawled : 20:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: -3.97%
H: 2.39%
C: -1.6%
update pharmaceuticals financial results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-05-02 (Crawled : 20:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 0.07%
H: 2.54%
C: 1.42%
conference update pharmaceuticals financial results
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Published: 2023-03-01 (Crawled : 22:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: -0.87%
H: 0.0%
C: -6.58%
pharmaceuticals year financial update results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
Published: 2023-02-22 (Crawled : 22:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 0.3%
H: 3.79%
C: 3.04%
pharmaceuticals conference year financial update results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 1.18%
H: 4.35%
C: 0.32%
pharmaceuticals conference financial update results
Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-09 (Crawled : 23:00) - biospace.com/
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: -0.13%
H: 1.24%
C: -0.63%
PCRX | $26.12 -2.43% -2.49% 620K
|
Health Technology
|
| O: 0.22%
H: 0.29%
C: -0.55%
update results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: 0.0%
conference results
Xenon Pharmaceuticals Reports 2021 Financial Results and Provides Corporate Update
Published: 2022-03-01 (Crawled : 23:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: -9.48%
H: 16.24%
C: 13.88%
als financial results report results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2021 Financial Results and Provide Corporate Update
Published: 2022-02-22 (Crawled : 22:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 1.23%
H: 3.1%
C: -10.88%
als financial results conference results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2021 Financial Results and Provide Corporate Update
Published: 2021-11-03 (Crawled : 20:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: -0.26%
H: 6.88%
C: 2.26%
financial results results conference
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101
Published: 2021-10-03 (Crawled : 00:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 69.5%
H: 22.03%
C: 18.82%
phase 2 results topline phase 2b trial conference
Xenon Pharmaceuticals Reports 2020 Financial Results and Provides Corporate Update
Published: 2021-03-01 (Crawled : 21:03) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 5.92%
H: 15.22%
C: 6.53%
financial results results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.